Health Condition 1: I502- Systolic (congestive) heart failure
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Dr. Reddy’s Laboratories Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female patients of Age greater or equal to 18 years 2.Patients diagnosed with Heart Failure with Ejection fraction lessthan 50% at baseline, who were prescribed CIDMUS for the first time or within one week. 3.Patients willing to provide consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Contraindications to the study drug as per physician’s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Ejection Fraction from baseline visit to follow-up visits 1,3,6, and 12 months in Heart failure patients on CIDMUS as per below sub groupsTimepoint: 1,3,6 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Safety assessment - Frequency and severity of AEs 2.Emergency visits due to HF requiring inotropic agents/iv diuretics at 1, 3,6, and 12 months 3.Incidence of hospitalization in HFrEF and HFmrEF patients on CIDMUS at 1,3,6, and 12 months 4.Incidence of cardiac death in HFrEF and HFmrEF patients on CIDMUS at 1,3,6, and 12 months 5.Change in NT-proBNP from baseline visit to follow-up visits 1,3,6, and 12 months in HFrEF and HFmrEF patients on CIDMUS 6. Change in NYHA class from baseline to 1,3,6, and 12 months in HFrEF and HFmrEF patients on CIDMUS 7.Average dose of the drug prescribed & compliance to therapyTimepoint: 1,3,6, and 12 months | — |
Countries
India
Contacts
Public ContactDr Sagar Katare
Dr. Reddy’s Laboratories Limited
Outcome results
None listed